Neopharm Group, established in 1941, is one of Israel’s leading providers of innovative integrated solutions across the spectrums of healthcare and life science.
Throughout the years, the group has evolved into a diversified health care company. At Neopharm Group, we specialize in building leadership and combining strengths in the areas of pharmaceuticals, biologic drugs, orphan drugs, vaccines, hospital products, medical devices, medical and scientific equipment, diagnostics, OTC, nutritionals, consumer healthcare products and home therapy.
Neopharm Group currently employs over 500 talented staff within 5 companies. We hold the prestigious rank of Israel’s second-largest marketing group in the Israeli healthcare and life science market. Our revenues exceed $300 million, making us the 58th largest Israeli company as per D&B’s Largest Israeli Enterprises 2011.
Our active sales and medical teams are deployed throughout the country and work to maintain the group’s top positioning in marketing and sales for branded pharmaceuticals and consumer health products. Also active in the field are teams of service engineers and application specialists who specialize in servicing our medical and life-science product line.